The impact of the epigenetic writer LSD1 in the cell cycle control in liver fibrosis and hepatocellular carcinoma

被引:1
|
作者
Wang, L. [1 ]
Yu, X. [1 ]
Schmiel, M. [1 ]
Steinheuer, L. [1 ]
Eischeid, H. [1 ]
Ulmer, B. [1 ]
Buettner, R. [1 ]
Odenthal, M. [1 ]
机构
[1] Univ Hosp Cologne, Pathol, Cologne, Germany
关键词
D O I
10.1016/S0168-8278(18)31640-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
SAT-188
引用
收藏
页码:S690 / S690
页数:1
相关论文
共 50 条
  • [41] Chemical inhibition of LSD1 leads to epithelial to mesenchymal transition in vitro of an oral squamous cell carcinoma OM-1 cell line via release from LSD1-dependent suppression of ZEB1
    Yamakado, Nao
    Okuda, Satoshi
    Tobiume, Kei
    Uetsuki, Ryo
    Ono, Shigehiro
    Mizuta, Kuniko
    Nakagawa, Takayuki
    Aikawa, Tomonao
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 647 : 23 - 29
  • [42] The impact of liver fibrosis on the progression of hepatocellular carcinoma via a hypoxia-immune-integrated prognostic model
    Li, Qianyuan
    Zhang, Junbo
    Xiao, Sheng
    Hu, Min
    Cheng, Jie
    Yao, Chenjiao
    Zhuang, Quan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [43] Liver-Specific Deletion of Prohibitin 1 Results in Spontaneous Liver Injury, Fibrosis, and Hepatocellular Carcinoma in Mice
    Ko, Kwang Suk
    Tomasi, Maria Lauda
    Iglesias-Ara, Ainhoa
    French, Barbara A.
    French, Samuel W.
    Romani, Komal
    Jose Lozano, Juan
    Oh, Pilsoo
    He, Lina
    Stiles, Bangyan L.
    Li, Tony W. H.
    Yang, Heping
    Martinez-Chantar, M. Luz
    Mato, Jose M.
    Lu, Shelly C.
    HEPATOLOGY, 2010, 52 (06) : 2096 - 2108
  • [44] LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells
    So-Young Lim
    Iris Macheleidt
    Priya Dalvi
    Stephan C. Schäfer
    Martin Kerick
    Luka Ozretić
    Sandra Ortiz-Cuaran
    Julie George
    Sabine Merkelbach-Bruse
    Jürgen Wolf
    Bernd Timmermann
    Roman K. Thomas
    Michal R. Schweiger
    Reinhard Buettner
    Margarete Odenthal
    Scientific Reports, 7
  • [45] LSD1 modulates the non-canonical integrin β3 signaling pathway in non-small cell lung carcinoma cells
    Lim, So-Young
    Macheleidt, Iris
    Dalvi, Priya
    Schaefer, Stephan C.
    Kerick, Martin
    Ozretic, Luka
    Ortiz-Cuaran, Sandra
    George, Julie
    Merkelbach-Bruse, Sabine
    Wolf, Juergen
    Timmermann, Bernd
    Thomas, Roman K.
    Schweiger, Michal R.
    Buettner, Reinhard
    Odenthal, Margarete
    SCIENTIFIC REPORTS, 2017, 7
  • [46] Anti-Stanniocalcin 1 antibody as a potential therapeutic strategy for liver fibrosis and hepatocellular carcinoma
    Suen, Alfred Long-Hin
    Chan, Kristy Kwan-Shuen
    Lo, Regina Cheuk-Lam
    CANCER RESEARCH, 2023, 83 (07)
  • [47] The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
    Cabral, Loraine Kay D.
    Reyes, Peter Andrew C.
    Croce, Lory S.
    Tiribelli, Claudio
    Sukowati, Caecilia H. C.
    DIAGNOSTICS, 2021, 11 (10)
  • [48] Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
    Seliger, Barbara
    Handke, Diana
    Schabel, Elisabeth
    Bukur, Juergen
    Lichtenfels, Rudolf
    Dammann, Reinhard
    JOURNAL OF TRANSLATIONAL MEDICINE, 2009, 7
  • [49] Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
    Barbara Seliger
    Diana Handke
    Elisabeth Schabel
    Juergen Bukur
    Rudolf Lichtenfels
    Reinhard Dammann
    Journal of Translational Medicine, 7
  • [50] Normalization of the ATP1A1 Signalosome Rescinds Epigenetic Modifications and Induces Cell Autophagy in Hepatocellular Carcinoma
    Rajan, Pradeep Kumar
    Udoh, Utibe-Abasi S.
    Nakafuku, Yuto
    Pierre, Sandrine V.
    Sanabria, Juan
    CELLS, 2023, 12 (19)